Back to Search
Start Over
Oncopeptides seeks US FDA accelerated approval for melflufen in combo with dexamethasone to treat multiple myeloma
- Source :
- PharmaBiz. July 2, 2020
- Publication Year :
- 2020
-
Abstract
- Oncopeptides, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, announced that the company submits a New Drug Application (NDA) to the US Food and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.628303635